Clinical Trial Update: Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study

View source ↗

Summary

A clinical trial is evaluating the effect of agalsidase alfa on cardiac inflammation in Fabry disease patients using 18F-FDG PET-CMR imaging and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• agalsidase alfa (agalsidase alfa)

Snippet

Sponsor: Yonsei University | Conditions: Fabry Disease | Status: RECRUITING